Independent Director · Nurix Therapeutics, Inc. (NRIX)

Chair, Clinical and Commercialization Committee

Roy D. Baynes director compensation at Nurix Therapeutics: $669K

Fiscal year 2025 director compensation for Roy D. Baynes at Nurix Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Roy D. Baynes’s full pay file as a PDF — free

More than this page: up to 10 years of Roy’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Roy D. Baynes and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Nurix Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Nurix Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$44,479$0$624,307$0$668,786

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nurix Therapeutics, Inc. DEF 14A filed March 27, 2026, accession 0001140361-26-011492, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Nurix Therapeutics, Inc. filed document, accession 0001140361-26-011492. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2026.

Get the Nurix Therapeutics Board Governance Report

$668,786 Roy D. Baynes, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of March 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Nurix Therapeutics pays directors a $50,000 cash retainer and $157,509 in equity.

Committees

FY2025 · as the proxy prints them

Clinical and Commercialization (Chair)

The rest of the Nurix Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Anil KapurIndependent Director$217,926
David L. LaceyIndependent Director$226,571
Edward C. SaltzmanIndependent Director$220,218
Judith A. ReinsdorfIndependent Director$229,072
Julia P. GregoryIndependent Director$258,968
Paul M. SilvaIndependent Director$230,322
Roger DanseyIndependent Director$421,684

The full Nurix Therapeutics compensation record

free company brief

This page is one director within Nurix Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Nurix Therapeutics proxy · each links to its own free brief

Order NRIX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report